NRXS
Neuraxis, INC
NASDAQ · Healthcare · Biotechnology · US
$7.85
+1.95%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$7.62
From 52W high−10.90%
Volume194230.00
Market cap$98.58M
P/E (TTM)—
P/S (TTM)18.5x
Div yield—
Key dataOct 19, 2026
Open
$7.62
From 52W high
−10.90%
Volume
194230.00
Market cap
$98.58M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−12.1x
P/E (TTM)
—
RSI (14)
54.8
MomentumView details →
1D Return
+1.95%
YTD Return
+60.57%
SummaryUpdated Jun 1, 2026
NeurAxis, Inc. (NASDAQ:NRXS) is a specialized medical device company founded in 2011 and headquartered in Carmel, Indiana. Originally incorporated as Innovative Health Solutions, Inc., the company rebranded to NeurAxis in March 2022 and went public in August 2023. NeurAxis focuses on developing and commercializing neuromodulation therapy devices, primarily targeting pediatric gastrointestinal disorders through its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology.
Similar companies
Latest newsMore news →
Neuraxis, INC announced a medical policy coverage milestone that adds coverage for PENFS for 26 million people, bringing its national coverage footprint to more than 147 million covered lives.4d agoNeurAxis, Inc. appointed Craig Blanchard as its Chief Commercial Officer.21d agoNeurAxis announced that a major national health insurer issued a new medical policy covering its PENFS neuromodulation therapy, expanding access to over 18 million additional covered lives.33d ago